Search research articles
Contact Us
Filters
Showing results (101-110 of 138) with videos related to
Page
of 14
Sort By:
Scientific Reports
|
December 3, 2021
Application of information theoretic feature selection and machine learning methods for the development of genetic risk prediction models
Farideh Jalali-Najafabadi, Michael Stadler, Nick Dand, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 17, 2019
Changes in Immunosuppressive Treatment of Chronic Graft-versus-Host Disease: Comparison of 2 Surveys within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland
Daniel Wolff, Inken Hilgendorf, Eva Wagner-Drouet, et al.
Blood
|
April 12, 2012
Early autologous stem cell transplantation for chronic lymphocytic leukemia: long-term follow-up of the German CLL Study Group CLL3 trial
Peter Dreger, Hartmut Döhner, Fabienne McClanahan, et al.
Blood
|
December 15, 2011
Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation
Christoph Schmid, Myriam Labopin, Arnon Nagler, et al.
Bone Marrow Transplantation
|
December 6, 2025
Reduced intensity conditioning with 8 Gy total body irradiation in adult patients with acute lymphoblastic leukemia
Klaus Wethmar, Matthias Edinger, Kerstin Schäfer-Eckart, et al.
British Journal of Haematology
|
November 5, 2019
FLA-IDA salvage chemotherapy combined with a seven-day course of venetoclax (FLAVIDA) in patients with relapsed/refractory acute leukaemia
Rabia Shahswar, Gernot Beutel, Piroska Klement, et al.
British Journal of Haematology
|
November 24, 2018
Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMT
Christoph Schmid, Myriam Labopin, Nicolaas Schaap, et al.
Blood
|
February 26, 2013
TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial
Peter Dreger, Andrea Schnaiter, Thorsten Zenz, et al.
British Journal of Haematology
|
July 9, 2016
Impact of telomere length on the outcome of allogeneic stem cell transplantation for poor-risk chronic lymphocytic leukaemia: results from the GCLLSG CLL3X trial
Annika Scheffold, Billy Michael Chelliah Jebaraj, Sonia Jaramillo, et al.
Blood
|
March 22, 2014
Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Jan M Middeke, Min Fang, Jan J Cornelissen, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 138) with videos related to
Sort By:
Page
of 14
Scientific Reports
|
December 3, 2021
Application of information theoretic feature selection and machine learning methods for the development of genetic risk prediction models
Farideh Jalali-Najafabadi, Michael Stadler, Nick Dand, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 17, 2019
Changes in Immunosuppressive Treatment of Chronic Graft-versus-Host Disease: Comparison of 2 Surveys within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland
Daniel Wolff, Inken Hilgendorf, Eva Wagner-Drouet, et al.
Blood
|
April 12, 2012
Early autologous stem cell transplantation for chronic lymphocytic leukemia: long-term follow-up of the German CLL Study Group CLL3 trial
Peter Dreger, Hartmut Döhner, Fabienne McClanahan, et al.
Blood
|
December 15, 2011
Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation
Christoph Schmid, Myriam Labopin, Arnon Nagler, et al.
Bone Marrow Transplantation
|
December 6, 2025
Reduced intensity conditioning with 8 Gy total body irradiation in adult patients with acute lymphoblastic leukemia
Klaus Wethmar, Matthias Edinger, Kerstin Schäfer-Eckart, et al.
British Journal of Haematology
|
November 5, 2019
FLA-IDA salvage chemotherapy combined with a seven-day course of venetoclax (FLAVIDA) in patients with relapsed/refractory acute leukaemia
Rabia Shahswar, Gernot Beutel, Piroska Klement, et al.
British Journal of Haematology
|
November 24, 2018
Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMT
Christoph Schmid, Myriam Labopin, Nicolaas Schaap, et al.
Blood
|
February 26, 2013
TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial
Peter Dreger, Andrea Schnaiter, Thorsten Zenz, et al.
British Journal of Haematology
|
July 9, 2016
Impact of telomere length on the outcome of allogeneic stem cell transplantation for poor-risk chronic lymphocytic leukaemia: results from the GCLLSG CLL3X trial
Annika Scheffold, Billy Michael Chelliah Jebaraj, Sonia Jaramillo, et al.
Blood
|
March 22, 2014
Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Jan M Middeke, Min Fang, Jan J Cornelissen, et al.
Page
of 14